Cargando…

Practical Recommendations for a Selection of Inhaled Corticosteroids in COPD: A Composite ICO Chart

The use of inhaled corticosteroids (ICS) for the maintenance of bronchodilator treatment in patients with chronic obstructive pulmonary disease (COPD) is controversial. While some patients achieve clinical benefits, such as fewer exacerbations and improved symptoms, others do not, and some experienc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oishi, Keiji, Matsunaga, Kazuto, Yamamoto, Tasuku, Matsuda, Kazuki, Murata, Yoriyuki, Hirano, Tsunahiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953425/ https://www.ncbi.nlm.nih.gov/pubmed/36830583 http://dx.doi.org/10.3390/biom13020213

Ejemplares similares

Feasibility of Discontinuing Biologics in Severe Asthma: An Algorithmic Approach
por: Hamada, Kazuki, et al.
Publicado: (2021)

Utility of the Shortness of Breath in Daily Activities Questionnaire (SOBDA-Q) to Detect Sedentary Behavior in Patients with Chronic Obstructive Pulmonary Disease (COPD)
por: Yamaji, Yoshikazu, et al.
Publicado: (2023)

A Real-World Study of Achievement Rate and Predictive Factors of Clinical and Deep Remission to Biologics in Patients with Severe Asthma
por: Oishi, Keiji, et al.
Publicado: (2023)

Computed Tomography Lung Density Analysis: An Imaging Biomarker Predicting Physical Inactivity in Chronic Obstructive Pulmonary Disease: A Pilot Study
por: Murata, Yoriyuki, et al.
Publicado: (2023)

A New Dyspnea Evaluation System Focusing on Patients’ Perceptions of Dyspnea and Their Living Disabilities: The Linkage between COPD and Frailty
por: Oishi, Keiji, et al.
Publicado: (2020)

A trial of oral corticosteroids for persistent systemic and airway inflammation in severe asthma
por: Oishi, Keiji, et al.
Publicado: (2017)

Characteristics of 2017 GOLD COPD group A: a multicenter cross-sectional CAP study in Japan
por: Oishi, Keiji, et al.
Publicado: (2018)

A Novel Role of Growth Differentiation Factor (GDF)-15 in Overlap with Sedentary Lifestyle and Cognitive Risk in COPD
por: Hirano, Tsunahiko, et al.
Publicado: (2020)

Sequential Biotherapy Targeting IL-5 and IL-4/13 in Patients with Eosinophilic Asthma with Sinusitis and Otitis Media
por: Chikumoto, Ayumi, et al.
Publicado: (2022)

Neural Network Approach to Investigating the Importance of Test Items for Predicting Physical Activity in Chronic Obstructive Pulmonary Disease
por: Nakahara, Yoshiki, et al.
Publicado: (2023)

Non‐pneumophila Legionella species pneumonia with orange‐coloured sputum
por: Asami‐Noyama, Maki, et al.
Publicado: (2021)

A case of development of autoimmune pulmonary alveolar proteinosis during the treatment of hypersensitivity pneumonitis
por: Asami-Noyama, Maki, et al.
Publicado: (2023)

False-positive Elevation of Beta-D-glucan and Aspergillus Galactomannan Levels Due to Mendelson's Syndrome after Rice Aspiration
por: Yamamoto, Tasuku, et al.
Publicado: (2022)

Impact of Frailty on Hippocampal Volume in Patients with Chronic Obstructive Pulmonary Disease
por: Takahashi, Shun, et al.
Publicado: (2021)

Comorbid Conditions in Chronic Obstructive Pulmonary Disease: Potential Therapeutic Targets for Unmet Needs
por: Matsunaga, Kazuto, et al.
Publicado: (2020)

Medication persistence rates and predictive factors for discontinuation of antifibrotic agents in patients with idiopathic pulmonary fibrosis: a real-world observational study
por: Oishi, Keiji, et al.
Publicado: (2019)

Antineutrophil cytoplasmic antibody-negative granulomatosis with polyangiitis localized to the lungs
por: Ohteru, Yuichi, et al.
Publicado: (2022)

Cryptococcosis as a cause of organizing pneumonia
por: Chikumoto, Ayumi, et al.
Publicado: (2019)

Author Correction: The 1-minute sit-to-stand test to detect desaturation during 6-minute walk test in interstitial lung disease
por: Oishi, Keiji, et al.
Publicado: (2022)

The 1-minute sit-to-stand test to detect desaturation during 6-minute walk test in interstitial lung disease
por: Oishi, Keiji, et al.
Publicado: (2022)

Late-onset asthma: current perspectives
por: Hirano, Tsunahiko, et al.
Publicado: (2018)

Measurement of Blood Eosinophils in Asthma and Chronic Obstructive Pulmonary Disease
por: Hirano, Tsunahiko, et al.
Publicado: (2022)

Time To Revise COPD Treatment Algorithm
por: Matsunaga, Kazuto, et al.
Publicado: (2019)

Inhaled Corticosteroids and the Lung Microbiome in COPD
por: Keir, Holly R., et al.
Publicado: (2021)

Kinetics of COVID-19 mRNA primary and booster vaccine-associated neutralizing activity against SARS-CoV-2 variants of concern in long-term care facility residents: a prospective longitudinal study in Japan
por: Kakugawa, Tomoyuki, et al.
Publicado: (2023)

Deep Sternal Wound Tuberculosis with Hypo-gamma-globulinemia
por: Hamada, Kazuki, et al.
Publicado: (2018)

Platypnea‐orthodeoxia syndrome in a patient with ongoing COVID‐19
por: Asami‐Noyama, Maki, et al.
Publicado: (2022)

Inhaled corticosteroids in COPD and the risk of serious pneumonia
por: Suissa, Samy, et al.
Publicado: (2013)

Inhaled corticosteroids in COPD: Personalising the therapeutic choice
por: Shaw, J A, et al.
Publicado: (2018)

How inhaled corticosteroids target inflammation in COPD
por: Lea, Simon, et al.
Publicado: (2023)

Rational use of inhaled corticosteroids for the treatment of COPD
por: Quint, Jennifer K., et al.
Publicado: (2023)

Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms
por: Avdeev, Sergey, et al.
Publicado: (2019)

Inhaled corticosteroids and angiotensin-converting enzyme-2 in COPD
por: Lipworth, Brian, et al.
Publicado: (2021)

Inhaled corticosteroids can reduce osteoporosis in female patients with COPD
por: Liu, Shih-Feng, et al.
Publicado: (2016)

Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related
por: Koehorst-ter Huurne, Kirsten, et al.
Publicado: (2016)

Appropriate use of inhaled corticosteroids in COPD: the candidates for safe withdrawal
por: Yawn, Barbara P, et al.
Publicado: (2016)

The dose of inhaled corticosteroids in patients with COPD: when less is better
por: Izquierdo, José Luis, et al.
Publicado: (2018)

COPD and Osteoporosis: Associated Factors in Patients Treated with Inhaled Corticosteroids
por: Ozcakir, Suheda, et al.
Publicado: (2020)

Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD
por: Cheng, Shih-Lung, et al.
Publicado: (2017)

Inhaled corticosteroid normalizes some but not all airway vascular remodeling in COPD
por: Soltani, Amir, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hm8akd54r6n8hq8mh9dse1uaou